APA (7th ed.) Citation

Durma, A. D., Saracyn, M., Kołodziej, M., Jóźwik-Plebanek, K., Brodowska-Kania, D., Dmochowska, B., . . . Kamiński, G. (2024). Adverse Events of Radioligand Therapy in Patients with Progressive Neuroendocrine Neoplasms: The Biggest Eastern European Prospective Study. Cancers, 16(20), 3509. https://doi.org/10.3390/cancers16203509

Chicago Style (17th ed.) Citation

Durma, Adam Daniel, Marek Saracyn, Maciej Kołodziej, Katarzyna Jóźwik-Plebanek, Dorota Brodowska-Kania, Beata Dmochowska, Adrianna Mróz, Beata Kos-Kudła, and Grzegorz Kamiński. "Adverse Events of Radioligand Therapy in Patients with Progressive Neuroendocrine Neoplasms: The Biggest Eastern European Prospective Study." Cancers 16, no. 20 (2024): 3509. https://doi.org/10.3390/cancers16203509.

MLA (9th ed.) Citation

Durma, Adam Daniel, et al. "Adverse Events of Radioligand Therapy in Patients with Progressive Neuroendocrine Neoplasms: The Biggest Eastern European Prospective Study." Cancers, vol. 16, no. 20, 2024, p. 3509, https://doi.org/10.3390/cancers16203509.